(NYSE: GKOS) Glaukos's forecast annual revenue growth rate of 23.97% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.25%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.36%.
Glaukos's revenue in 2025 is $404,523,000.On average, 9 Wall Street analysts forecast GKOS's revenue for 2025 to be $27,437,966,337, with the lowest GKOS revenue forecast at $27,296,029,270, and the highest GKOS revenue forecast at $27,638,872,426. On average, 9 Wall Street analysts forecast GKOS's revenue for 2026 to be $35,204,849,474, with the lowest GKOS revenue forecast at $34,009,755,373, and the highest GKOS revenue forecast at $37,528,754,666.
In 2027, GKOS is forecast to generate $43,969,691,898 in revenue, with the lowest revenue forecast at $41,124,036,562 and the highest revenue forecast at $49,616,261,536.